IMDX
Insight Molecular DiagnosticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
IMDX vs peer average
49/100
IMDX vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · D 5 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
PRQR is the first available peer comparator.
Clinical-stage small-cap biotech with event-driven valuation swings; useful as a loose comparator for regulatory milestone sensitivity rather than business-model similarity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMDX
Insight Molecular Diagnostics
PRQR
ProQR Therapeutics
Grade
D
D
Momentum
12
34
Value
41
41
Sentiment
44
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs PRQR
IMDX / PRQR
Grade Position
In line
IMDX vs. peer average (D vs. D)
49/100
Momentum
12
PRQRValue
41
IMDXSentiment
44
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMDX
PRQR is the first peer returned for this comparison set.